Apotex Health seeks to raise up to C$1.2 billion, potentially reviving Toronto IPO market

Apotex Health is seeking up to C$1.2 billion in an IPO on the Toronto Stock Exchange (41.7–50M shares at C$20–24).
The offering is one of the first major TSX listings this year and could help revive Canada’s subdued IPO market.
Toronto-based Apotex serves about 70 countries and has grown ~8% over four years by moving beyond generics into specialty generics, brands and biosimilars.